Overcoming antibody-resistant SARS-CoV-2 variants with bispecific antibodies constructed using non-neutralizing antibodies.
Inoue T, Yamamoto Y, Sato K, Okemoto-Nakamura Y, Shimizu Y, Ogawa M, Onodera T, Takahashi Y, Wakita T, Kaneko MK, Fukasawa M, Kato Y, Noguchi K.
Inoue T, et al. Among authors: okemoto nakamura y.
iScience. 2024 Feb 29;27(4):109363. doi: 10.1016/j.isci.2024.109363. eCollection 2024 Apr 19.
iScience. 2024.
PMID: 38500835
Free PMC article.